Sodium chlorite. EV FL500ML 3MEQ ML
Active ingredient SODIUM CHLORIDE INTRAVENOUS ADDITIVE SOLUTIONS therapeutic
Group Product Type
GENERIC DRUG MAKES NO SSN scheme
Class C Type Recipe OSP
Form Farm. INJECTIONS container BOTTLE
Validity Date Commerc 36 months. 01/12/2005
ATC B05XA03
Producer Price Monica Spa
Pharmacotherapeutic
ADDITIVE intravenous solutions. INDICATIONS
The solution 'referred to as exogenous sodium and chlorine in the course of
Total Parenteral Nutrition (TPN) in adult and pediatric
and in which' established a deficiency of these ions in response to excessive
or diuresis to excessive salt restriction.
CONTRAINDICATIONS / EFF.SECONDAR
In patients with hypernatremia. Pregnancy and lactation. Give
and only if clearly needed '.
DOSAGE The dosage of sodium chloride and 'established on the basis of the age' of p
eso, clinical conditions, electrolyte balance and acid bas
and patient. The dosage and 'then according to requirements met
abolish the patient identified on the basis of laboratory data and clinical evaluation of
. The product should be used exclu sively
as a solution to be added to mixes for the NPT. Tratt
asi a concentrated solution for which and not 'planned chief
direct administration only after dilution in a large volume of fluid
.
INTERACTIONS
Please refer the user to the scientific literature.
SIDE EFFECTS
hypervolemia or symptoms associated with a deficiency or an excess of one or more
'ions in the solution. Excessive administration of sodium
can 'cause hypernatremia and high cloridremia can' cause
bicarbonate loss with acidifying. Febrile responses, tr
Ombos venous phlebitis. In case of adverse reaction stop s
omministrazione and uphold the
not given for any examinations. The patient 'called for tell your doctor or pharma cist
any side effects not listed in this leaflet
TiVo. Use immediately after opening the container. The solution should be
clear, colorless and free of visible particles.
need for a single, uninterrupted administration and any residue can not '
be used. Do not inject as such but only after appropriate d
iluizione and mixing. Use with great caution in patients co
n congestive heart failure, severe renal insufficiency and in stat
clinicians and edema associated with salt and water retention;
t reatment in patients with corticosteroid drugs and corticotrophin. Monitors the budget are
fluids, electrolytes, osmolality '
plasma and acid-base balance.
0 comments:
Post a Comment